Amarin Corp Plcuk (AMRN) Other Working Capital Changes (2010 - 2026)
Amarin Corp Plcuk (AMRN) reported Other Working Capital Changes of $2.0 million for Q1 2026, down 84.34% year-over-year from $12.6 million in Q1 2025, and down 84.35% quarter-over-quarter from $12.6 million in Q4 2025.
Amarin Corp Plcuk (AMRN) Other Working Capital Changes (2010 - 2026) Analysis & Trends
Amarin Corp Plcuk (AMRN) has 17 years of Other Working Capital Changes data on file, last reported at $2.0 million in Q1 2026.
- Other Working Capital Changes for Q1 2026 came in at $2.0 million, down 84.34% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.8 million (down 77.25% YoY), and the FY2025 annual result was $5.2 million, up 1234.96% from the prior year.
- Other Working Capital Changes fell to $2.0 million in Q1 2026 per AMRN's latest filing, from $12.6 million in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $24.3 million in Q2 2023 and troughed at -$34.2 million in Q3 2023.
- A 5-year average of -$72375.0 and a median of $260000.0 in 2022 frame the typical range for Other Working Capital Changes.
- On a YoY basis, Other Working Capital Changes climbed as much as 5338.42% in 2022 and fell as far as 905.78% in 2022.
- A 5-year view of Other Working Capital Changes shows it stood at -$5.5 million in 2022, then surged by 145.79% to $2.5 million in 2023, then slumped by 1092.15% to -$24.8 million in 2024, then jumped by 150.79% to $12.6 million in 2025, then tumbled by 84.35% to $2.0 million in 2026.
- Business Quant data shows AMRN's Other Working Capital Changes at $2.0 million in Q1 2026, $12.6 million in Q4 2025, and -$115000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Gsk | 92,316,836.42 Bn | 92,316,831.46 Bn | 7.76 Bn |
| 2 | Eli Lilly | 983.57 Bn | 978.29 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 553.56 Bn | 531.50 Bn | 15.96 Bn |
| 4 | AbbVie | 383.35 Bn | 374.00 Bn | 10.78 Bn |
| 5 | Merck | 281.71 Bn | 276.06 Bn | 12.09 Bn |
| 6 | Amgen | 182.20 Bn | 170.16 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 153.71 Bn | 145.98 Bn | 5.52 Bn |
| 8 | Pfizer | 143.75 Bn | 130.98 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 109.71 Bn | 99.25 Bn | 8.07 Bn |
| 10 | Amarin Corp Plcuk | 6.77 Bn | 6.59 Bn | 17.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.97 Mn |
| Mar 31, 2026 | 1.97 Mn |
| Dec 31, 2025 | 12.59 Mn |
| Dec 31, 2025 | 12.59 Mn |
| Sep 30, 2025 | -115,000.00 |
| Sep 30, 2025 | -115,000.00 |
| Jun 30, 2025 | -12.59 Mn |
| Jun 30, 2025 | -12.59 Mn |
| Mar 31, 2025 | 12.58 Mn |
| Mar 31, 2025 | 12.58 Mn |
| Sep 30, 2024 | -24.78 Mn |
| Sep 30, 2024 | -24.78 Mn |
| Jun 30, 2024 | 20.34 Mn |
| Jun 30, 2024 | 20.34 Mn |
| Mar 31, 2024 | -401,000.00 |
| Mar 31, 2024 | -401,000.00 |
| Dec 31, 2023 | 2.50 Mn |
| Dec 31, 2023 | 2.50 Mn |
| Sep 30, 2023 | -34.19 Mn |
| Sep 30, 2023 | -34.19 Mn |